SCHEMBL16964228

SCHEMBL16964228

NC(=O)CC(O)(C(N)=O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.50
KMT2A Q03164 1/20 0.50
HTT P42858 1/20 0.46
KCNN4 O15554 6/20 0.44
CYP2C19 P33261 2/20 0.44
HIF1A Q16665 1/20 0.44
KIF11 P52732 2/20 0.40
LMNA P02545 1/20 0.39
CHRM2 P08172 1/20 0.39
CYP2D6 P10635 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
KCNH2 Q12809 1/20 0.39
CYP1A2 P05177 1/20 0.39
SCN5A Q14524 3/20 0.39
SCN9A Q15858 3/20 0.39
KDM4E B2RXH2 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
POLB P06746 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28252431 0.88 PLA2G10 (0.50) MAPTKMT2AHTTKCNN4CYP2C19
SCHEMBL3994296 0.81 MAPT (0.57) MAPTKMT2AHTTKCNN4CYP2C19
SCHEMBL10483830 0.81 MAPT (0.47) MAPTKMT2AHTTKCNN4CYP2C19
SCHEMBL7102456 0.80 MAPT (0.47) MAPTKMT2AHTTKCNN4KIF11
SCHEMBL3837958 0.79 MAPT (0.55) MAPTKMT2AHTTKCNN4CYP2C19
SCHEMBL27602772 0.79 MAPT (0.50) MAPTKMT2AHTTKCNN4CYP2C19
SCHEMBL13946510 0.79 MAPT (0.55) MAPTKMT2AHTTKCNN4CYP2C19
SCHEMBL13946506 0.79 MAPT (0.55) MAPTKMT2AHTTKCNN4CYP2C19
SCHEMBL3350095 0.79 CHRM3 (0.50) MAPTKMT2AHTTKCNN4CYP2C19
SCHEMBL1492535 0.78 KIF11 (0.48) MAPTKMT2AHTTKCNN4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111778313-B Angiotensin converting enzyme assay kit, preparation method and application 武汉生之源生物科技股份有限公司 2022-11-18 CN disclosed
CN-109776411-B Nitrogen mustard carbostyril derivative and preparation method and application thereof 石家庄学院 2022-06-07 CN disclosed
CN-109781923-B Method for simultaneously and rapidly determining multiple amino acids and sugars in soy sauce Rizhao Customs Integrated Technical Service Center (CN) 2021-06-22 CN disclosed
CN-111778313-A Angiotensin converting enzyme assay kit, preparation method and application 武汉生之源生物科技股份有限公司 2020-10-16 CN disclosed
CN-111433003-A Three-dimensional printing 惠普发展公司,有限责任合伙企业 2020-07-17 CN disclosed
US-9585891-B2 Alpha hydroxy amides MERCK PATENT GMBH (DE) 2017-03-07 US disclosed
US-20150250792-A1 ALPHA HYDROXY AMIDES MERCK PATENT GMBH (DE) 2015-09-10 US disclosed
EP-2900633-A1 ALPHA HYDROXY AMIDES Merck Patent GmbH (DE) 2015-08-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150250792-A1 ALPHA HYDROXY AMIDES HCAR1, NAA40, HCAR2 MAPT 2545/4885KMT2A 1072/4885HTT 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.